| Name | N-Trityl Candesartan |
|---|---|
| Synonyms |
Tricycliccandestan(C9)
2-ethoxy-3-[[4-[2-[1-(triphenylmethyl)-5-tetrazolyl]phenyl]phenyl]methyl]-4-benzimidazolecboxylic acid 2-ethoxy-1-[[(2-(1-triphenylmethyl-1Htetrazol-5-yl)biphenyl-4-yl-) Trityl candestan //BP Candestan Cilexetil Intermediate 5 Trityl candestan/2-Ethoxy-1-[[(2'-(1-triphenylmethyl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl]benzimidazole-7-cboxylic acid 2-ethoxy-1-[[(2'-(1-triphenylmethyl-1h-tetrazol-5-yl)biphenyl-4-yl)methyl]benzimidazole-7-cboxylic acid 2-Ethoxy-1-{[2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid 1H-Benzimidazole-7-cboxylic acid, 2-ethoxy-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl] Trityl Candestan (C9) 2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-cboxylic Acid DISCONTINUED 2-ETHOXY-1-[[(2-(1-TRIPHENYLMETHYL-1H-TETRAZOL-5-YL)BIPHENYL)METHYL] BENZIMIDAZOLE-7-CARBOXYLIC ACID 2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-cboxylic acid 2-Ethoxy-1-[[(2’-(1-triphenylmethyl-1H-tetrazol-5-yl)biphenyl-4-yl-)methyl]benzimidazole-7-cboxylicacid TRITYL CANDESTAN ( FOR CANDESTAN CILEXETIL ) 2-Ethoxy-1-[[2-(2-Triphenylmethyl)-2H-Tetrazole-5-Yl](1,1-Biphenyl)-4-Yl]-Methyl]Benzimidazole-7-Cboylicacid (Trityl candestan)2-Ethoxy-1-[[2-(2-Triphenyl Methyl)-2H-Tetrazole-5-YL](1,1-Biphenyl)-4-YL]Methyl]Benzimidazole-2-Cboxylic Acid N-tityl candestan Candesartan Cilexetil Impurity 14 2-Ethoxy-1-[[2-[2-(Triphenylmethyl)-2H-Tetrazol-5- Yl][1,1-Biphenyl]-4-Yl]Methyl]-1H-Benzimidazole-7- Cboxylic Acid [N-Trityl Candestan] Trityl Candesatan Triphenyl Candestan 2-Ethoxy-1-{[2'-(1-trityl-1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylic acid 2-ETHOXY-1-[[(2-(1-TRIPHENYLMETHYL-1H-TETRAZOL-5-YL)BIPHENYL)METHYL] BENZIMIDAZOLE-7-CBOXYLIC ACID Candestan Cilexetil Impurity 9 Candestan Impurity 8 Candestan N1-Trityl IMpurity TritylCandestan[CandestabCilexetilIntermediates] CANDESTAN INTERMEDIATE A 1H-benzimidazole-7-cboxylic acid, 1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-2-ethoxy N-Trityl Candestan Candestan Cilexetil Impurity 14 Triphenyl candestan ester Trityl candestan (Candestan Cilexetil Impurity) TRITYL CANDESTAN N-trimethylcandestan (1H)-Benzimidazole-7-cboxylicacid 2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-c TritylCandestan,CandestanCilexetil 2-Ethoxy-1-[[2'-(N-triphenylmethyltetrazol-5-yl)-biphenyl-4-yl]methyl]benzimidazole-7-cboxylic acid 2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 908.6±75.0 °C at 760 mmHg |
| Melting Point | 163-165ºC |
| Molecular Formula | C43H34N6O3 |
| Molecular Weight | 682.768 |
| Flash Point | 503.3±37.1 °C |
| Exact Mass | 682.269226 |
| PSA | 107.95000 |
| LogP | 10.15 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.678 |
| Storage condition | Refrigerator |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2933990090 |
|
~88%
139481-72-4 |
| Literature: Alembic Limited Patent: US2010/210852 A1, 2010 ; Location in patent: Page/Page column 5 ; |
|
~%
139481-72-4 |
| Literature: US6177587 B1, ; |
|
~%
139481-72-4 |
| Literature: WO2011/145100 A1, ; |
|
~%
139481-72-4 |
| Literature: WO2011/145100 A1, ; |
|
~%
139481-72-4 |
| Literature: WO2011/145100 A1, ; |
|
~%
139481-72-4 |
| Literature: WO2011/145100 A1, ; |
|
~%
139481-72-4 |
| Literature: WO2011/145100 A1, ; |
|
~%
139481-72-4 |
| Literature: WO2011/145100 A1, ; |
|
~%
139481-72-4 |
| Literature: WO2011/145100 A1, ; |
| Precursor 10 | |
|---|---|
| DownStream 2 | |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |